Skip to main content
en
fr
Search form
Search
Main menu
About us
Our Company Purpose
Our mission
Facts & Figures
Our Strategy
Corporate Governance / Executive Committee
bioMérieux Worldwide
Our History
Innovation
Institut Mérieux
Responsibility
Our ambition
Health
Planet
Healthcare ecosystem
Employees
Extended Company
RESISTANCE TO ANTIBIOTICS
COVID-19 EXCEPTIONAL DONATIONS
Solutions
Clinical Solutions
Industry Solutions
Product Quality & Safety
Customer Service
Cybersecurity
Resource Center
CLINICAL SOLUTIONS
INDUSTRY SOLUTIONS
Expertise
The importance of diagnostics
Clinical diagnostics
Industrial Microbiological Control
Clinical applications
Infectious diseases
COVID-19
Antimicrobial resistance and Healthcare-associated infections
Cardiovascular Emergencies
Personalized medicine
Industrial applications
Agri-food sector
Biopharma & cosmetics sectors
Our technologies, systems and services
Microbiology
Molecular Biology
Immunoassays
Services
Glossary of Scientific Terms
Education
Antimicrobial Resistance / Antimicrobial Stewardship
Webinars
Educational Tutorials
Educational Materials
External Resources
Sepsis / Bloodstream Infections
Webinars
Educational Tutorials
Educational Materials
External Resources
Microbiology
COVID-19
Webinars
Educational Materials
Acute Kidney Injury
Webinars & Symposiums
Educational Materials
External Resources
Cardiac Emergencies
Educational Tutorials
Educational Materials
Educational booklets
Investors
The bioMérieux Share
Publications
Regulated Information
Governance
Shareholder area
UNIVERSAL REGISTRATION DOCUMENT
CORPORATE SOCIAL RESPONSIBILITY
Newsroom
Press Releases
Corporate calendar
Media Center
About bioMérieux
French multidisciplinary consortium ARPEGE awarded public funding of close to €9 million to fight antibiotic resistance
PRESS CONTACTS
Careers
Joining bioMérieux
Corporate culture
Public health mission
International presence
Professional development
Diversity and inclusion
Well-being at work
Compensation and benefits
Job Profiles
R&D
Manufacturing
Supply Chain
Information Systems
Quality
Business
Support Functions
Medical Affairs
HSE
Clinical Affairs and Regulatory Affairs
Contact us
About us
Our Company Purpose
Our mission
Facts & Figures
Our Strategy
Corporate Governance / Executive Committee
bioMérieux Worldwide
Our History
Innovation
Institut Mérieux
Responsibility
Our ambition
Health
Planet
Healthcare ecosystem
Employees
Extended Company
Solutions
Clinical Solutions
Industry Solutions
Product Quality & Safety
Customer Service
Cybersecurity
Resource Center
Expertise
The importance of diagnostics
Clinical applications
Industrial applications
Our technologies, systems and services
Glossary of Scientific Terms
Education
Antimicrobial Resistance / Antimicrobial Stewardship
Sepsis / Bloodstream Infections
Microbiology
COVID-19
Acute Kidney Injury
Cardiac Emergencies
Educational booklets
Investors
The bioMérieux Share
Publications
Regulated Information
Governance
Shareholder area
Newsroom
Press Releases
Corporate calendar
Media Center
About bioMérieux
Careers
Joining bioMérieux
Job Profiles
Contact us
Investor Relations
Press Contacts
en
fr
Search form
Search
bioMérieux Corporate Website |
Pioneering diagnostics
Our Company Purpose
Discover our Company Purpose!
Corporate News
bioMérieux is now certified in 2 regions and 13 countries!
COVID-19
FAQ on our commitment to fight against COVID-19
Investors
Discover our investors-dedicated section
Press releases
January 06, 2022
French multidisciplinary consortium ARPEGE awarded public funding o...
December 14, 2021
Corporate Social Responsibility: bioMérieux recently received a se...
December 10, 2021
bioMérieux – Increased outlook for full-year 2021
December 01, 2021
bioMérieux molecular tests efficiently detect SARS-CoV-2 Omicron v...
